A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.
about
Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalIs it ethical to prescribe generic immunosuppressive drugs to renal transplant patients?Generic immunosuppression in transplantation: current evidence and controversial issues.Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
P2860
A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A randomized, crossover pharma ...... of kidney transplant patients.
@en
A randomized, crossover pharma ...... of kidney transplant patients.
@nl
type
label
A randomized, crossover pharma ...... of kidney transplant patients.
@en
A randomized, crossover pharma ...... of kidney transplant patients.
@nl
prefLabel
A randomized, crossover pharma ...... of kidney transplant patients.
@en
A randomized, crossover pharma ...... of kidney transplant patients.
@nl
P2093
P2860
P356
P1476
A randomized, crossover pharma ...... of kidney transplant patients.
@en
P2093
P2860
P304
P356
10.1111/CTR.12256
P577
2013-10-11T00:00:00Z